In patients with septic shock, a correlation between positive fluid balance and worsened outcomes has been reported in multiple observational studies worldwide. No published data exists in an Australasian cohort. We set out to explore this association in our institution. We conducted a retrospective audit of patient records from August 2012 to May 2015 in a single-centre, 24-bed surgical and medical intensive care unit (ICU) in Sydney, Australia. All patients with septic shock were included. Exclusion criteria included length of stay less than 24 hours or vasopressors needed for less than six hours. Data was gathered on fluid balance for the first seven days of ICU admission, biochemical data and other clinical indices. The primary outcome measure was survival to hospital discharge. One hundred and eighty-six patients with septic shock were included, with an overall hospital mortality of 23.7%. Seventy-five percent of patients required mechanical ventilation, and 27.4% required haemodialysis. The mean daily fluid balance on the first day of admission was positive 1,424 ml and 1,394 ml for ICU and hospital survivors, respectively. On average, the daily fluid balance for non-survivors was higher than the survivors: ICU non-survivors were 602 (95% confidence intervals 230, 974) ml (P=0.0015) and hospital non-survivors were 530 [95% confidence intervals 197, 863] ml (P=0.0017) higher than the survivors. In line with other recently published data, after adjustment for confounders (severity of illness based on the Acute Physiology and Chronic Health Evaluation score) we found a correlation between positive fluid balance and worsened hospital mortality in critically ill patients with sepsis and septic shock. Further research investigating rational use of fluids in this patient group is needed.
Sepsis and septic shock cause significant mortality and morbidity in the spectrum of patients requiring intensive care admission in both Australasia and worldwide 1 . Intravenous fluid therapy is a ubiquitous component of management for septic shock, as evidenced by the Surviving Sepsis guidelines 2 , where significant volumes of intravenous fluid are often prescribed in conjunction with early broadspectrum antibiotics. The latest iteration of these guidelines recommends 30 ml/kg of intravenous crystalloid fluid to be given in the first three hours, which is described as usual practice. Further fluid administration is recommended to be guided by frequent assessment of haemodynamic status. However, the optimum volume of fluid and targets for fluid resuscitation are not well elucidated. Models describe septic shock as a primarily vasodilatory state 3 , not a fluid depleted state 4 . Evidence also demonstrates administration of intravenous fluids in high volumes leads to capillary endothelial glycocalyx disruption 5 . Recent studies have also shown improved outcomes in patients with septic shock achieving negative fluid balance during their 'recovery' 6 and worse outcomes with more positive fluid balance 7 , including a direct correlation between fluid balance and mortality 8 . Investigators in the FEAST (Fluid Expansion As Supportive Therapy) trial 9 halted recruitment after interim analyses found a significant rise in mortality in children with 'febrile hypotension' who received fluid bolus therapy.
Minimal data on this topic from Australasia exists, and the only study to date is a retrospective analysis of the RENAL (Randomised Evaluation of Normal versus Augmented Level of Replacement Therapy) study, which found an association between negative fluid balance and improved mortality in critically ill patients receiving renal replacement therapy 10 . We aimed to perform a retrospective analysis over a threeyear period, in a single centre, in patients with sepsis and septic shock as defined by the new guidelines from the Society of Intensive Care Medicine and the European Society of Intensive Care Medicine. We hypothesised that both intensive care unit (ICU) and hospital non-survivors would have a more positive fluid balance than survivors.
Materials and methods
We performed a retrospective single-centre audit in a 24-bed mixed medical and surgical, adult ICU at Nepean Hospital, Sydney, New South Wales. Ethics approval was granted by the Blue Mountains Human Research and Ethics Committee (reference 15/22). The need for informed consent was waived due to the observational, retrospective nature of the study. Data was obtained by review of electronic patient records from August 2012 to May 2015. A patient list was generated from the Australian and New Zealand Intensive Care Society adult patient database for all patients admitted to Nepean ICU using any diagnostic codes for sepsis or infections. Patients were included in this list if they met the criteria for sepsis or septic shock as defined by guidelines from the Society of Intensive Care Medicine and the European Society of Intensive Care Medicine 11 . Sepsis is defined as a syndrome of life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is defined as that of sepsis with underlying circulatory and cellular abnormalities profound enough to substantially increase mortality, clinically identified by those patients requiring vasopressors to maintain a mean arterial pressure greater than 65 mmHg (8.7 kPa), and with a serum lactate of >2 mmol/l despite adequate volume resuscitation. Exclusion criteria included missing data, vasopressors not prescribed or required for less than six hours, antibiotic treatment for presumed sepsis not commenced, death within 24 hours, pregnancy, or age less than 16 years.
Data was collected on demographics, Sequential Organ Failure Assessment (SOFA) score, length of ICU and hospital stays, duration of ventilation, origin of referral, ICU and hospital mortality, need for renal replacement therapy, microbiological data, baseline pH, lactate and relevant biochemical and haematological variables, taken as the worst value within 24 hours of admission. To determine the measured fluid balance, the separately recorded intravenous (including drug infusions), oral and nasogastric fluid inputs were combined for total daily inputs and then total fluid output calculated from urine, dialysis, drain, vomitus and stool volumes. Insensible losses were not estimated. Day 0 was calculated as time of ICU admission to 2359 hours that day. Primary outcome was survival to hospital discharge. Secondary outcomes included ICU mortality, ICU and hospital length of stay, need for renal replacement therapy and duration of ventilation.
Statistical analysis
JMP version 11.2 was used for statistical analysis (SAS Institute, Cary, NC, USA). Categorical variables were reported as number and percentage, and analysed with Fisher's exact test or chi-squared test, and Spearman's rank test was used for correlation. Continuous variables are reported as mean (± standard deviation [SD]) or median (± interquartile range [IQR]) if not normally distributed. Two-tailed t-tests were used for normally distributed continuous variables, and Mann-Whitney U tests for non-parametric data. P values less than 0.05 were considered statistically significant.
The association of daily fluid balance data with mortality was analysed using a two-level mixed effect regression model (lme4 v1.1-12 and nlme v3.1-131 packages in R) as a linear regression model was insufficient to account for the individual and daily variations of daily fluid balance. Level 1 was the time (day) in ICU or hospital (day 0 to day 6 since ICU admission), and level 2 was the subjects. Mortality (ICU or hospital) was used as a grouping variable. A first-order autoregressive error structure was used for covariance structure. Day 0 was designated as the first day in ICU. Two separate models were built, one for ICU mortality and the other hospital mortality. Subjects with incomplete or missing data were excluded and a total of 186 patients were included in the regression analysis. The dependent variable was daily fluid balance, and the predictors were mortality (yes=1/no=0) and the day in ICU or hospital. Disease severity at admission and body weight were identified as potential confounders for fluid administration. These time-invariant confounders were represented by the Acute Physiology and Chronic Health Evaluation (APACHE) III score and body weight (kg). The subjects and the change in daily fluid balance with time were specified as random factors. Model selections were performed using stepwise addition of variables starting from a null model containing only the subjects as random factors. Further model building was achieved by forward selection of covariates, including APACHE III score and body weight. Goodness of fit between models was compared by likelihood ratio test. The final models contained mortality and day in ICU or hospital as quadratic terms, the random terms (intercept and coefficient) and APACHE III score (Tables x and y, see supplemental data). There was no evidence supporting group-time interactions (P=0.167 and 0.561 for ICU and hospital mortality, respectively), hence the interaction term was dropped from the final model.
Results

Baseline characteristics and comparisons
Seven hundred and fifty-four patients were screened and a total of 186 with septic shock identified. Baseline demographic, mortality and physiological data are presented in Table 1 . Similar baseline characteristics were seen between survivors and non-survivors in terms of age, sex and past medical history. There was a hospital mortality rate of 23.7% (19/186 female, 43%) and ICU mortality of 17.7% (15/186; female 45%). Most admissions were from inter-hospital transfers, followed by admissions through the emergency department. A greater proportion of non-survivors were mechanically ventilated (86% versus 72%, P=0.07) and needed renal replacement therapy (39% versus 24%, P=0.08), although neither achieved statistical significance. Nonsurvivors tended to have higher SOFA scores (12 versus 11, P=0.023), APACHE III scores (90 versus 76, P=0.0001), lower white cell counts (11.7 versus 16.5 x 10 9 /l, P=0.030), haemoglobin concentrations (94 versus 111 g/l, P=0.034) and platelet levels (139 versus 202 x 10 9 /l, P=0.010). Nonsurvivors had a longer duration of vasopressor therapy (51 versus 35 hours, P <0.002).
Blood cultures were positive in 39% (72/186) of patients, with the most common organism being Staphylococcus aureus, followed by Streptococcus species. Microbiology results are presented in Table 3 . The most common locations of infection based on clinical diagnosis were the lung, followed by the gastrointestinal tract. Data is represented as median and interquartile range, unless otherwise specified. MET, medical emergency team; COPD, coronary obstructive pulmonary disease; IHD, ischaemic heart disease; CKD, chronic kidney disease; SOFA, Sequential Organ Failure Assessment; APACHE, Acute Physiology and Chronic Health Evaluation; PF, oxygen partial pressure to fractional inspired oxygen. Data is represented as median and interquartile range, unless otherwise specified. ICU, intensive care unit; RRT renal replacement therapy. Figures 1 and 2 show the box plots for daily fluid balance for hospital and ICU survivors and non-survivors, respectively. Both graphs show a daily decrease in mean daily fluid balance in ICU for both survivors and non-survivors. These changes were accurately predicted by the mixed effects models (predicted changes are superimposed on the boxplots as dashed or solid lines).
After adjusting for disease severity (APACHE III score), the mean daily fluid balance on day 0 (first day of admission) was 1,424 ml and 1,394 ml for ICU and hospital survivors, respectively. On average, the daily fluid balances for nonsurvivors was higher than the survivors: ICU non-survivors were 602 (95% confidence interval [CI]:230, 974) ml (P=0.0015) and hospital non-survivors were 530 (197, 863) ml (P=0.0017) higher than the survivors. On individual levels, there were also mild negative correlations between daily fluid balance on day 0 and the change in daily fluid balance: patients who had a higher day 0 balance were associated with a faster decrease in daily fluid balance (i.e. steeper slopes). Raw data from daily fluid inputs and outputs are presented in Figures 3 and 4 .
Discussion
The results of our analysis show that after adjustment for severity of illness, a strong association exists between more positive fluid balance and both hospital and ICU mortality in this cohort of patients with septic shock.
A wealth of information is becoming apparent from recent studies: Murphy et al 6 performed a retrospective analysis of patients with acute lung injury and septic shock and found lower rates of mortality both in those who had adequate early fluid resuscitation and conservative late fluid management (defined as achieving an even to negative fluid balance on two consecutive days within the first seven days). At seven days, non-survivors received a mean of 5,632 ml more intravenous fluids than survivors. Jia et al 12 examined risk factors for development of the acute respiratory distress syndrome (ARDS) in patients receiving mechanical ventilation and found that those who developed ARDS had a more positive fluid balance (10.6 litres versus 6.7 litres). A secondary analysis of the ARDSnet trial by Rosenberg et al 13 found those who achieved negative fluid balance had improved hospital mortality and ICU length of stay, and shorter duration of ventilation. The Sepsis Occurrence in Acutely Ill Patients (SOAP) study 14 , a large prospective observational study in Europe, also found cumulative fluid balance and daily fluid balance were associated with increased mortality. They noted that each litre increase in daily fluid balance raised the odds ratio of death by 1.8. Acheampong et al 8 recently published data showing a strong association between positive fluid balance and mortality. They prospectively analysed fluid balance over seven days in patients with septic shock, and found daily fluid balance was more than twice as large in survivors compared to nonsurvivors.
Some conflicting evidence exists however. Chang et al 15 examined the volume of intravenous fluid administered to patients within the first 24 hours of admission to their ICU for septic shock and the development of ARDS. After adjusting for confounders, they found no significantly increased risk of ARDS with more intravenous fluid administration.
The latest iteration of the Surviving Sepsis guidelines recommends an initial 30 ml/kg intravenous fluid bolus for all patients with septic shock, described as usual practice 16 . It is also recommended that further fluid administration be guided by ongoing haemodynamic assessment using physical examination, vital signs and haemodynamic monitoring where available. It is likely that the majority of patients with septic shock are concurrently suffering from a degree of hypovolaemia, and intravenous fluids have a role in the management of these patients, but individualised decisionmaking in regard to fluid administration has been shown to be very difficult in clinical practice.
Saugel et al 17 demonstrated no correlation between physical examination-based estimation of volume status and invasively determined fluid status by intensive care specialists. The pharmacodynamics of a small volume fluid challenge were assessed by Hollman et al 18 who, amongst other data, found that mean arterial pressure was not useful in assessing response to a fluid challenge, and the effects of a fluid challenge on all haemodynamic variables dissipated by ten minutes. That is, there was no difference in the change in mean arterial pressure between responders (defined as an increase in cardiac output of 10%) and non-responders, and the clinical use of a small volume fluid challenge may be appropriate diagnostically, but the therapeutic application appears to be less useful.
The Fluid Challenges in Intensive Care (FENICE) study brings to light further issues. This large prospective observational study found that 47% of the time no variable is used to predict fluid responsiveness, the most commonly used variable to assess response to fluid challenges is blood pressure, and the response to a fluid challenge made no difference in the likelihood of prescription of a further fluid challenge 19 .
Limitations of our study included the retrospective data analysis. Issues arose with the electronic file analysis in that fluids administered prior to ICU admission were not recorded, and this limited our ability to assess initial volume of fluid resuscitation. This resulted in us focusing our attention to the management within our ICU. Further, we could not accurately comment on our experience in regard to the observed trend to better outcome with 'positive early, negative late' fluid balance. Strengths of our study include the inclusion of all patients over a near three-year period and the robust statistical methods we have applied. We also found our mortality and positive blood culture results were similar to larger studies performed in Australasia, which adds some validity 20 .
A further unanswered question is the optimal timing of vasopressors 21, 22 , the use of which is logically intertwined with fluids in the treatment of septic shock. It appears a commonsense approach to fluid therapy in sepsis would involve an awareness of our own bias and avoidance of cognitive 'cherry picking' of parameters to suit that bias, an appreciation of the pharmaceutical nature of intravenous fluids, coupled with a thorough understanding of fluid responsiveness and how to test for it.
Conclusion
This study adds to the growing volume of research containing thought-provoking data suggesting a conservative approach to fluid therapy in sepsis and septic shock may confer improved outcomes. Further rigorous prospective randomised trials are urgently needed to help clarify the optimal strategy in this complex syndrome. Realistically, however, it is certainly possible that sweeping generalisations with the goal of generating a 'one-size-fits-all' approach to such a heterogeneous syndrome may not be achievable. 
Supplemental data
Rather, developing a rapid, simple and reproducible way to assess for fluid responsiveness at the bedside would provide an invaluable tool to provide individualised care to patients with septic shock.
